ARKK, ARKQ and ARKX did the buying. Here are the day's other moves, and how ARK is doing against the market.

Generated from ARK's own holdings data.
ARK Invest bought roughly $25.9M of Rocket Lab (RKLB) on 23 Sep 2026, spread across ARKK and ARKQ and ARKX. No other trade that day was bigger.
Strip out the 1.1% that every holding moved as money came into the funds, and RKLB still grew 19%. That excess is what we count as a trade.
Over the last 30 days ARK has been a net buyer of Rocket Lab — $70.3M across 7 trades.
ARK made 8 real moves that day, once money flowing in and out of the funds is stripped out:
| Stock | Funds | Est. value |
|---|---|---|
| RKLB Rocket Lab | ARKK, ARKQ and ARKX | +$25.9M |
| GOOGL Alphabet Inc | ARKQ and ARKX | −$5.8M |
| TXG 10X Genomics Inc | ARKG | −$4.0M |
| TWST Twist Bioscience Corp | ARKG | −$3.5M |
| SCTX Scribe Therapeutics IncBought after a 11% drop this week | ARKG | +$2.5M |
| P Everpure Inc | ARKW | −$2.1M |
Over the last 30 days ARK's biggest net buys have been Meta Platforms Inc ($73.6M), Rocket Lab ($70.3M), Nvidia Corp ($53.0M). On the other side, it has been cutting Advanced Micro Devices ($122.8M), Tempus AI Inc ($58.8M), Twist Bioscience Corp ($46.6M).
This year ARKK is ahead of the market — +18.0% against +14.0% for the S&P 500.
That five-year gap — 107 points — mostly comes down to timing. Five years ago ARKK was trading close to its all-time high of Feb 2021. It then fell 81% to its low in Dec 2022, and it is still 41% below that peak today. Any comparison that starts near the top of that boom looks brutal.
| To date | 1 month | YTD | 1 year | 5 years |
|---|---|---|---|---|
| ARKK | +5.8% | +18.0% | +11.2% | -21.2% |
| S&P 500 (SPY) | +0.9% | +14.0% | +18.5% | +85.8% |
| Nasdaq-100 (QQQ) | +4.8% | +21.5% | +25.9% | +105.3% |
ETFpeek is an independent research tool and is not affiliated with ARK Invest or Cathie Wood. Figures are estimates from public fund data, shown for information only — not financial advice. Past performance does not indicate future results.